ChaoHuiHuangMDFACP

Clinical Trials

• S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Start of enrollment: 2004 Oct 01

  Completed

  Phase 2

• Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2004 Sep 01

  Completed

  Phase 2

• Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01

  Active, not recruiting

  Phase 3

• Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2007 Feb 01

  Terminated

  Phase 1

• Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer Start of enrollment: 2007 Jun 01

  Terminated

  Phase 2

• S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2008 Dec 01

  Completed

  Phase 2

• Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy Start of enrollment: 2008 Jul 01

  Unknown status

  Phase 2

• MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer Start of enrollment: 2009 Jun 01

  Completed

  Phase 2

• An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2009 Jan 01

  Completed

  Phase 1

• S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2009 May 01

  Completed

  Phase 2

• S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15

  Terminated

  Phase 3

• Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC) Start of enrollment: 2010 Jul 01

  Completed

• Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01

  Terminated

  Phase 2, Phase 3

• Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer Start of enrollment: 2013 Sep 09

  Terminated

  Phase 1

• A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants Start of enrollment: 2013 Aug 01

  Completed

  Phase 2

• Join now to see all